Recent_JJ studies_NNS have_VBP identified_VBN homologues_NNS of_IN STAT5_NN ,_, STAT5A_NN ,_, and_CC STAT5B_NN ,_, as_RB well_RB as_IN lower_JJR molecular_JJ weight_NN variants_NNS of_IN STAT5_NN ._.
To_TO delineate_VB the_DT effects_NNS of_IN these_DT motifs_NNS on_IN the_DT replicative_JJ capacity_NN of_IN HIV_NN and_CC to_TO explore_VB the_DT possibility_NN of_IN extending_VBG the_DT virus_NN host_NN range_NN ,_, known_VBN heterologous_JJ were_VBD inserted_VBN into_IN the_DT HIV-1_NN LTR_NN in_IN place_NN of_IN the_DT NF-kappa_NN B_NN and_CC Sp1_NN binding_NN sites_NNS ._.
BCL-2-deficient_JJ T_NN cells_NNS demonstrate_VBP accelerated_VBN cell_NN cycle_NN progression_NN and_CC increased_VBN apoptosis_NN following_VBG activation_NN ._.
n-Acetyl-L-cysteine_NN NAC_NN ,_, a_DT potent_JJ antioxidant_NN ,_, blocked_VBD NF-kappa_NN B_NN activation_NN caused_VBN by_IN IL-4_NN and_CC by_IN anti-CD40_JJ mAb_NN ._.
In_IN agreement_NN with_IN this_DT finding_NN ,_, Northern_NN experiments_NNS where_WRB p65_NN and_CC p105_NN mRNA_NN levels_NNS were_VBD determined_VBN ,_, demonstrated_VBD that_IN expression_NN of_IN these_DT components_NNS of_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN were_VBD not_RB affected_VBN by_IN IL-10_NN or_CC IL-4_NN ._.
The_DT lymphoid-specific_JJ transcription_NN complex_NN ,_, NF-AT_NN ,_, is_VBZ involved_VBN in_IN early_JJ gene_NN activation_NN in_IN T_NN cells_NNS and_CC is_VBZ assembled_VBN from_IN a_DT pre-existing_JJ ,_, T_NN cell_NN restricted_JJ cytoplasmic_JJ factor_NN and_CC an_DT inducible_JJ ubiquitous_JJ nuclear_JJ component_NN within_IN 30_CD min_NN after_IN activation_NN through_IN the_DT antigen_NN receptor_NN ._.
These_DT studies_NNS demonstrate_VBP that_IN CMV_NN may_MD be_VB an_DT important_JJ cofactor_NN in_IN the_DT development_NN of_IN rejection_NN and_CC infection_NN after_IN transplantation_NN through_IN effects_NNS on_IN IL-6_NN ._.
In_IN this_DT report_NN ,_, we_PRP describe_VBP the_DT phenotype_NN of_IN mouse_NN transgenic_JJ lines_NNS obtained_VBN by_IN inducing_VBG tal-1_NN protein_NN expression_NN in_IN lymphoid_JJ tissues_NNS using_VBG the_DT LCK_NN promoter_NN ._.
These_DT results_NNS confirm_VBP and_CC extend_VBP the_DT notion_NN of_IN the_DT functional_JJ conservation_NN of_IN the_DT AIR-1_JJ gene_NN product_NN across_IN species_NNS barriers_NNS ._.
Regulation_NN of_IN glucocorticoid_NN receptors_NNS in_IN human_JJ mononuclear_JJ cells_NNS :_: effects_NNS of_IN glucocorticoid_NN treatment_NN ,_, Cushing_NN disease_NN and_CC ketoconazole_NN ._.
